Skip to main content
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1985 Nov;28(5):663–666. doi: 10.1128/aac.28.5.663

Comprehensive evaluation of ciprofloxacin-aminoglycoside combinations against Enterobacteriaceae and Pseudomonas aeruginosa strains.

I Haller
PMCID: PMC176353  PMID: 2936301

Abstract

The in vitro activities of antibiotic combinations containing ciprofloxacin and either gentamicin, sisomicin, netilmicin, amikacin, or tobramycin were evaluated by checkerboard assay (agar dilution method). A total of 220 strains of Enterobacteriaceae and Pseudomonas aeruginosa (11 species, 20 strains each) were tested. Synergistic or antagonistic effects were observed in less than 1% of the tests performed; they appeared to represent method-dependent fluctuations rather than true antibiotic interactions. No significant differences among the five aminoglycosides tested were seen. Time-kill experiments performed with three representative strains of Escherichia coli and Serratia marcescens showed additive combination effects with respect to the kill rates and inhibition of bacterial regrowth. Exposure of Serratia strains to either ciprofloxacin or gentamicin before the addition of the second drug had little influence on the combination effects observed. No antagonistic drug interactions were seen in vivo when combination therapy with ciprofloxacin and gentamicin was evaluated in a model of E. coli thigh muscle infection in neutropenic mice. Comparable therapeutic effects were obtained, regardless of whether the two compounds were administered simultaneously or sequentially at 1- or 2-h intervals.

Full text

PDF
663

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bertram M. A., Young L. S. Imipenem antagonism of the in vitro activity of piperacillin against Pseudomonas aeruginosa. Antimicrob Agents Chemother. 1984 Aug;26(2):272–274. doi: 10.1128/aac.26.2.272. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. ELION G. B., SINGER S., HITCHINGS G. H. Antagonists of nucleic acid derivatives. VIII. Synergism in combinations of biochemically related antimetabolites. J Biol Chem. 1954 Jun;208(2):477–488. [PubMed] [Google Scholar]
  3. Hallander H. O., Dornbusch K., Gezelius L., Jacobson K., Karlsson I. Synergism between aminoglycosides and cephalosporins with antipseudomonal activity: interaction index and killing curve method. Antimicrob Agents Chemother. 1982 Nov;22(5):743–752. doi: 10.1128/aac.22.5.743. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Overbeek B. P., Rozenberg-Arska M., Verhoef J. Interaction between ciprofloxacin and tobramycin or azlocillin against multiresistant strains of Acinetobacter anitratum in vitro. Eur J Clin Microbiol. 1985 Apr;4(2):140–141. doi: 10.1007/BF02013583. [DOI] [PubMed] [Google Scholar]
  5. Peterson L. R., Gerding D. N., Moody J. A., Fasching C. E. Comparison of azlocillin, ceftizoxime, cefoxitin, and amikacin alone and in combination against Pseudomonas aeruginosa in a neutropenic-site rabbit model. Antimicrob Agents Chemother. 1984 May;25(5):545–552. doi: 10.1128/aac.25.5.545. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Rudin J. E., Norden C. W., Shinners E. M. In vitro activity of ciprofloxacin against aerobic gram-negative bacteria. Antimicrob Agents Chemother. 1984 Oct;26(4):597–598. doi: 10.1128/aac.26.4.597. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Verbist L., Verhaegen J. Effect of temocillin in combination with other beta-lactam antibiotics. Antimicrob Agents Chemother. 1984 Jan;25(1):142–144. doi: 10.1128/aac.25.1.142. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Wise R., Andrews J. M., Edwards L. J. In vitro activity of Bay 09867, a new quinoline derivative, compared with those of other antimicrobial agents. Antimicrob Agents Chemother. 1983 Apr;23(4):559–564. doi: 10.1128/aac.23.4.559. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Zeiler H. J., Grohe K. The in vitro and in vivo activity of ciprofloxacin. Eur J Clin Microbiol. 1984 Aug;3(4):339–343. doi: 10.1007/BF01977490. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES